MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202641096627 A) filed by Vellore Institute Of Technology on August 10, 2026, for Nebulized Nanoemulsion Formulation For Targeted Pulmonary Delivery Of Antituberculosis Drugs.
Inventors include Natarajan Chandrasekaran; Dr. George Priya Doss C; and Dr. Mohanraj Gopikrishnan.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates to a nebulized nanoemulsion formulation and system for targeted pulmonary delivery of antituberculosis drugs. The formulation comprises a eugenol-based oil phase, Tween 80 as a surfactant, and an aqueous phase, wherein a lipophilic drug, rifampicin, is...